Hybrid cell lines were prepared by the fusion of mouse myeloma cells with the spleen cells of Wistar-Furth rats that had been immunized with a Moloney sarcoma virus (Mo-MuSV)-induced tumour, MFU. Two immunization protocols were designed. In the first, the animals received several injections of irradiated (10000 rad) cells of a tumour cell line established in vitro, MFU-67. The rats received a booster injection 3 days prior to fusion. In the second protocol, immunization was the result of simple tumour growth, and no booster was given. Hybrids were tested by immunofluorescence for the production of immunoglobulins reacting with mouse cells acutely infected with Mo-MuSV. Over 20% of reactive hybrids were observed in the tumour growth protocol, and about 10% in the irradiated cell protocol when the last injection of the series was given 2 weeks before fusion. After 6 months, the proportion fell to 3%. Hybrid lines producing antibody to p30, the major core polypeptide of murine retroviruses, were obtained by cloning. Three of these were selected for closer study and were found to recognize three non-overlapping epitopes on p30. By direct and competitive binding in ELISA tests, the three epitopes were found to have very different distribution patterns among the various strains and isolates of murine retroviruses.
BallJ. K.,
McCarterJ. A.,
SunderlandS. M.1973; Evidence for helper independent murine sarcoma virus. I. Segregation of replication-defective and transformation-defective viruses. Virology 56:268–294
ChesebroB.,
BrittW.,
EvansL.,
WehrlyK.,
NishioJ.,
CloydL.1983; Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134–148
ChuatJ. C.,
LasquellecF.,
L’HirondelA. M.,
BoironM.1971; Studies on mouse sarcoma virus. II. Detection of group-specific antigen by immunofluorescence. International Journal of Cancer 7:101–111
ChuatJ. C.,
LaprevotteI.,
BoironM.1975; Repartition des variants iso-electriques du polypeptide principal (p30) dans differentes souches d’oncornavirus murins. Comptes rendus hebdomadaires des seances de I’Academie des sciences D281:1051–1054
ChuatJ. C.,
LaprevotteI.,
BernardC.,
PilonC.1978; The isoelectric point of the p30 polypeptide as a marker of mouse endogenous viruses. Journal of General Virology 38:169–173
DevauxJ.,
BernardC.,
TavitianA.1980; Etude d’un virus produit par des cellules embryonnaires humaines infectees par le virus du sarcome murin de Moloney. Comptes rendus hebdomadaires des seances de I’Academie des sciences D291:71–74
FischingerP. J.1980; Type C RNA transforming viruses. In Molecular Biology of RNA Tumor Viruses pp 163–198 Edited by
StephensonJ. R.
New York & London: Academic Press;
FrakerP. J.,
SpeckJ. C.1978; Protein and cell membrane iodinations with a sparingly soluble chloroamide, l, 3, 4, 6-tetrachloro-3α, 6α-diphenyl glycoluril. Biochemical and Biophysical Research Communications 80:849851
GambkeC.,
SennH. P.,
HunsmannG.,
SchumannG.,
MoroniC.,
AlkanS. S.1984; Monoclonal antibodies recognizing structural components of murine retroviruses including an FMR antigen on protein p12. Journal of General Virology 65:1507–1517
GuilhotS.,
ChuatJ. C.1983; A 38, 000 molecular weight gag-related protein in a Moloney sarcoma virus-induced tumour cell line. Annates de Virologie 134E:3–30
HartleyJ. W.,
RoweW. P.,
CappsW. I.,
HuebnerR. J.1965; Complement fixation and tissue culture assays for mouse leukemia viruses. Proceedings of the National Academy of Sciences, U.S.A 53:931–938
JamjoomC. A.,
NasoR. B.,
ArlinghausR. B.1977; Further characterization of intracellular precursor proteins of Rauscher leukemia virus. Virology 78:11–34
LostromM.,
StoneM. R.,
MiltonT.,
BurnetteW. N.,
PinterA.,
NowinskiR. C.1979; Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants of the pi5(E) and gp70 envelope proteins. Virology 98:336–350
MedgyesiG. A.,
FustG.,
GergelyJ.,
BazinH.1978; Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. Immunochemistry 15:125–129
NowinskiR. C.,
LostromM. E.,
TamM. R.,
StoneM. R.,
BurnetteW. N.1979; The isolation of hybrid cell lines producing monoclonal antibodies against the pl5(E) protein of murine leukemia viruses. Virology 93:111–126
OroszlanS.,
GildenR. V.1980; Primary structure analysis of retrovirus proteins. In Molecular Biology of RNA Tumor Viruses pp 299–344 Edited by
StephensonJ. R.
New York & London: Academic Press;
ReddyE. P.,
SmithM. J.,
CanaaniE.,
RobbinsK. C.,
TronickS. R.,
ZainS.,
AaronsonS. A.1980; Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proceedings of the National Academy of Sciences, U.S.A 77:5234–5238
StephensonJ. R.,
TronickS. R.,
AaronsonS. A.1974; Analysis of type specific antigenic determinants of two structural polypeptides of mouse RNA C-type virus. Virology 58:1–8
StrandM.,
AugustJ. T.1974; Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. Journal of Virology 13:171–180
Van BeverenC.,
GalleshawJ. A.,
JonasV.,
BernsA. Y. M.,
DoolittleR. F.,
DonoghueD. J.,
VermaI. M.1981; Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus. Nature, London 289:258–262
Van ZaaneD.,
GielkensA. L. J.,
Dekker-MichielsenM. J. A.,
BloemersH. P. J.1975; Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology 67:544–552